Eagle Pharmaceuticals Inc (EGRX)
0.6501
-0.05
(-7.19%)
USD |
OTCM |
Nov 15, 10:00
Eagle Pharmaceuticals Gross Profit (Annual)
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 221.67M |
| December 31, 2021 | 129.37M |
| December 31, 2020 | 142.34M |
| December 31, 2019 | 135.00M |
| December 31, 2018 | 151.40M |
| December 31, 2017 | 179.52M |
| Date | Value |
|---|---|
| December 31, 2016 | 134.18M |
| December 31, 2015 | 50.58M |
| September 30, 2014 | 7.385M |
| September 30, 2013 | 6.298M |
| September 30, 2012 | -0.627M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
129.37M
Minimum
2021
221.67M
Maximum
2022
157.09M
Average
138.67M
Median
Gross Profit (Annual) Benchmarks
| Eli Lilly and Co | 27.04B |
| Verrica Pharmaceuticals Inc | 4.378M |
| NovaBay Pharmaceuticals Inc | 7.895M |
| Palatin Technologies Inc | 4.392M |
| iBio Inc | -- |